Delivery Order SPE2DB20D1100-SPE2DB24FA4K6
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the specialty pharmaceutical drug BENLYSTA. The $1,259.50 contract has a completion date of February 26, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under an indefinite delivery contract (IDC) with a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 400 mg vials of the pharmaceutical BENLYSTA. The contract has a potential value of $1,259.50 and a completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the pharmaceutical product BENLYSTA. The $1,259.50 order has a completion date of March 12, 2024 and was awarded on February 20, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the pharmaceutical drug BENLYSTA. The contract has a potential value of $1,259.50 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,557 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the supply of 400 mg vials of the pharmaceutical product BENLYSTA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to military treatment programs and facilities...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company Amerisourcebergen Corporation, to supply 400 mg vials of the specialty biologic medication BENLYSTA. The $7,557.00 delivery order has a completion date of March 13, 2024 and was awarded on February 21, 2024. This order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued up to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,259.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BENLYSTA 400 MG vials. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BENLYSTA 400 MG vials. The delivery order has a ceiling value of $2,519.00 and a period of performance through April 1, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 400 mg vials of the drug BENLYSTA. The contract has a potential value of $13,854.50 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the pharmaceutical drug BENLYSTA. The order has a completion date of March 18, 2024 and a potential value of $1,259.50. Amerisourcebergen Drug Corp is a prime contractor for DLA, providing a wide range of pharmaceutical products and medical supplies to support military treatment programs and facilities....
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA4K6Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 400 mg vials of the pharmaceutical product BENLYSTA. The delivery order, valued at $1,259.50, has a completion date of March 19, 2024 and was awarded on February 27, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 2/27/24 |